Board Leadership

LSC    About

FILTER BY

George  Scangos, Ph.D.

George Scangos, Ph.D.

Former CEO

Vir Biotechnology

Amanda  Banks

Amanda Banks

Former CEO, Co-Founder

Blackfynn

Aisha Baro

Aisha Baro

Executive Director

Life Science Cares Bay Area

Scott Bechtler-Levin

Scott Bechtler-Levin

Head of Venture Design

Redesign Health

Robert Blum

Robert Blum

President & CEO

Cytokinetics

Terry-Ann Burrell

Terry-Ann Burrell

CFO

Beam Therapeutics

Carin  Canale-Theakston

Carin Canale-Theakston

CEO and Founder

Evoke Canale

Abe Ceesay

Abe Ceesay

CEO

Rapport Therapeutics

Chip Clark

Chip Clark

Entrepreneur in Residence

SROne Capital Management

Thomas Daniel

Thomas Daniel

Chairman, Board of Overseers & Director

The Scripps Research Institute

Michael Dougherty

Michael Dougherty

Biopharmaceutical Executive & Board Member

Cindy Dunkle

Cindy Dunkle

Chief People Officer

Denali Therapeutics

Jonathan Fassberg

Jonathan Fassberg

Founder

astr partners

Wainwright Fishburn

Wainwright Fishburn

Partner, Global Head of Digital Health

Cooley LLP

Jennifer Fox

Jennifer Fox

Chief Business Officer | Chief Financial Officer

Zenas BioPharma

Michael Gaito

Michael Gaito

Global Head of Healthcare Investment Banking

JP Morgan

Carol G. Gallagher, Pharm.D.

Carol G. Gallagher, Pharm.D.

Venture Partner

New Enterprise Associates

George Golumbeski

George Golumbeski

Partner

Droia Ventures

Faheem Hasnain

Faheem Hasnain

Chairman & co-founder

Gossamer Bio Chairman of Mirati, Aspen Neuroscience & Sente Inc. Lead Director, Kura Oncology

Jeff Hessekiel

Jeff Hessekiel

Executive Vice President, General Counsel and Secretary

Exelixis

Richard Heyman

Richard Heyman

Vice Chairman of the
Board of Trustees

Salk Institute for Biological Studies

Jeb Keiper

Jeb Keiper

CEO

Nimbus Therapeutics

Nina Kjellson

Nina Kjellson

President & CEO

Canaan

Seema  Kumar

Seema Kumar

CEO

Cure

Peter Lafer

Peter Lafer

Principal, Life Sciences

General Atlantic

Ted W. Love, MD

Ted W. Love, MD

Chair of the Board

Biotechnology Innovation Organization - BIO

John Maraganore

John Maraganore

Founding CEO (Former)

Alnylam

Jeff Marrazzo

Jeff Marrazzo

Former Co-Founder and CEO

Spark Therapeutics

Cynthia Mazareas

Cynthia Mazareas

Partner

WilmerHale

Mark McClung

Mark McClung

(Former) Executive Vice President and Chief Operating Officer

Sangamo Therapeutics, Inc.

David Melville

David Melville

CEO

The Bowdoin Group

Vin Milano

Vin Milano

Former CEO

Idera Pharmaceuticals

Patricia Millican

Patricia Millican

Chief Financial Officer

Architect Therapeutics

Shawnte Mitchell

Shawnte Mitchell

Chief Legal Officer and General Counsel

Genomatica

Chris Molineaux

Chris Molineaux

President and CEO

Life Sciences Pennsylvania

Jodie Morrison

Jodie Morrison

CEO

Q32 Bio

Matt Outten

Matt Outten

Chief Commercial Officer

BridgeBio

Deb Palestrant

Deb Palestrant

Partner & Executive Chair, 459 Initiative

5AM Ventures

Peter Pedro

Peter Pedro

Executive Vice President

Marsh & McLennan Agency

Rob Perez

Rob Perez

Operating Partner

General Atlantic

Dennis Purcell

Dennis Purcell

Founder and Senior Advisor

Aisling Capital

Jim Reddoch

Jim Reddoch

CSO & EVP, Investments

Royalty Pharma

Kristin Reed

Kristin Reed

Executive Director, Corporate and Employee Giving & the Genentech Foundation

Genentech

Rene Russo

Rene Russo

CEO

Xilio Therapeutics

Mark Sanchez, Ed.D.,

Mark Sanchez, Ed.D.,

President and Superintendent

Southwestern College

Lynn Seely, M.D.

Lynn Seely, M.D.

President & Chief Executive Officer

Lyell Immunopharma

Mike Tomsicek

Mike Tomsicek

Chief Financial Officer (Former)

CRISPR Therapeutics

Nolan Townsend

Nolan Townsend

CEO

LEXEO Therapeutics

Robert Urban

Robert Urban

Global Head of Innovation (Former/Retired)

J&J Innovation

Kate Wilson

Kate Wilson

President, Gilead Foundation

Gilead Sciences

Load More
Bitcore Method
AI Bit Invest
AI Bit Invest